3,4-Dichloro-n-propylbenzene-1-sulfonamide, 95%, 1g

(R)-1-Methyl-piperidin-3-ylamine, 95.0%, 250mg

1-Methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 95.0%, 25g

6-Methoxy-3,4-dihydronaphthalen-1-yl trifluoromethanesulfonate, 98%, 5g

4-Ethoxy-3-trifluoromethyl-phenylamine, 97.0%, 1g

Glycine, N-(2,6-dimethylphenyl)-, 97%, 250mg

1-amino-2-hydroxynaphthalene-4-sulfonic acid, min. 90%, pa, ACS, 25 g, glass packaging

(1r)-1-(2-Bromo-4-fluorophenyl)ethan-1-ol, 98%, 2.5g

4-Bromotoluene>99.0%(GC)500g

1-[(2,4-DIMETHOXYPHENYL)METHYL]-4-(HYDROXYMETHYL)PYRROLIDIN-2-ONE, 95.0%, 5g

ethyl 4-chloro-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate, 95.0%, 500mg

3,4-Dibromotoluene, 99.0%, 10g

2-(4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL)PHENYL)-1,1,1-TRIFLUOROPROPAN-2-OL, 95.0%, 250mg